Daniel Markes - 31 Dec 2025 Form 5 Insider Report for CQENS Technologies Inc.

Reporting relationship: Chief Financial Officer, Director
Issuer ticker: N/A
Reported as of: 31 Dec 2025
Net transaction value: $0
SEC form: 5
Accepted by SEC: 15 Apr 2026, 16:01:09 UTC
Prior SEC filing: 25 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Daniel Markes

Key filing fact

Daniel Markes filed Form 5 for CQENS Technologies Inc. on 15 Apr 2026.

Key facts

This page summarizes Daniel Markes's Form 5 filing for CQENS Technologies Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Apr 2026, 16:01.

Change

Previous filing in this sequence was filed on 25 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647589 Primary reporting owner

Markes Daniel

Relationship: Chief Financial Officer, Director
Address: 170 S GREEN VALLEY PARKWAY, SUITE 343, HENDERSON,
Signature: /s/ Daniel Markes
Signature date: 15 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
Shares: +50,000
Change %
Price: $0.000000^*
Shares after: 50,000
Date: 31 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $20.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The grant of stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The stock options are fully vested and granted under the Issuer's 2019 Executive Compensation Plan.